Ideas
Memory stocks risk supply-driven collapse.
Memory and storage names such as SanDisk, Western Digital, Micron, and Kioxia have had parabolic moves and are printing money because of a real shortage, but semiconductor capital equipment will eventually add enough capacity. No chip shortage lasts more than about two years, and even the first sign of demand waning or supply catching up can knock the stocks down. Cut positions sizably, take profits, and let only a small remainder run.
Hold gold and silver as insurance.
Gold and silver have had parabolic moves, but if investors own them as hedges or insurance rather than speculation, Cramer blesses holding them. If they are speculating, he says take out the cost basis and let the rest run.
Trim tech and diversify.
Large-cap tech is underperforming to start the year and too much tech exposure is risky after a huge run. Cramer disagrees that tech will simply come back, says the investing club is spreading into other secular themes, and advises taking profits if a portfolio has 40% or more in tech.
Diversify into non-tech sectors.
With tech underperforming and froth in speculative names, Cramer says better relative opportunities are in non-data-center tech, consumer goods, retail, aerospace, banking, and healthcare. Those groups have acted much better than tech, so investors should diversify into them.
Hold Novo on oral GLP-1 lead.
Cramer would hold Novo Nordisk. He met with the CEO, likes the company, thinks it is making a turn, and views its head start in the oral GLP-1 pill as very good.
Sell Spotify; revisit lower later.
Spotify is shedding points as the Street turns on high price-to-sales multiple stocks. Cramer says investors have to obey that trend, watch it come in and own it for the long term, or sell it and come back later, which may be his preferred approach.
Small-cap leadership is unhealthy.
The Russell 2000 being the market leader is a bad sign. Cramer notes small caps are up nearly 7% to start the year, but many companies do not make money, are overvalued on earnings per share, and some have little revenue. It is not a good leadership group.
Take profits in alt-energy froth.
Alternative energy and nuclear names have exploded as data centers seek clean energy, but many are unprofitable or extremely expensive. Bloom Energy trades around 150 times earnings, EOS Energy is up sharply, and nuclear names like Oklo, NuScale, and Nano Nuclear do not make money while new nukes will not arrive soon. Cramer treats this as froth and wants profits taken.
Space stocks are unprofitable froth.
Space names like AST SpaceMobile, Redwire, and Rocket Lab have rallied sharply despite losing money. Cramer wonders whether investors are just hiding there until a possible SpaceX deal, and he views the group as unprofitable froth to trim.
Drone stocks too expensive, no catalyst.
Drone and defense names like Kratos, AeroVironment, and Red Cat are up sharply. Cramer likes Kratos and AeroVironment because they are profitable, but they are incredibly expensive and lack real catalysts beyond presidential saber rattling.
Take profits in crypto-AI miners.
Crypto miners converting their racks into AI data centers, including CoreWeave, Nebius, IREN, Applied Digital, and Riot Platforms, have made insane moves. Cramer says take profits before they are cut in half.
Sell crypto-related names.
Galaxy Digital and Figure Technology have popped 44% and 76% even as the broader crypto market seems stuck. Cramer responds explicitly with sell, sell, sell.
Trim leveraged silver ETF mania.
The ProShares Ultra Silver ETF is a leveraged bet on silver that has had enormous gains and a 10.7% one-day move. Cramer calls it a speculative mania and wants some taken off the table tomorrow.
Rare-earth metal stocks frothy.
United States Antimony and Critical Metals Corp have posted enormous year-to-date gains, with Critical Metals up 147% as a rare earth elements producer. Cramer treats these moves as froth in metals and rare earth names.
Biotech froth is boom-bust.
Biotech was a large part of Cramer's froth list, with many names doubling. But biotech is a boom-and-bust leadership group where gains can disappear quickly, especially when companies raise money and rally on press releases.
AI secondary offerings crush Rezolve.
Rezolve AI has rallied as an ambiguous AI story and had positive revenue pre-announcements, but then announced a $250 million secondary offering that crushed shareholders. Cramer expects many similar offerings.
Mortgage froth vulnerable to rates.
LoanDepot had a 55% year-to-date gain as a housing-related froth name, then plunged more than 12% as long-term rates rose. Cramer warns investors to get used to those kinds of declines.
Wait on Dell margin pressure.
Cramer likes Dell, but Dell is a big buyer of tight-supply storage, Micron, and disk drives. Suppliers keep raising prices to Dell, forcing Dell to eat the costs and hurting margins. He says wait until Dell reports or until storage and Micron pricing peaks.
Data-center cooling plays face sentiment risk.
Cramer says Vertiv, Emerson, and Eaton will still be used to get electricity into and cool Nvidia chips, and he is not backing away from them. However, the market currently dislikes data-center plays, so he warns against starting new positions and wants sales if investors are too exposed or on margin.
Take profits in ImmunityBio.
ImmunityBio had a giant run after an FDA meeting. Cramer advises taking profits in some, though not all, of the position because it is already up so much.
Wait to buy Pan American.
Pan American Silver is the best silver mining company, but starting a position after such a huge move is worrisome. Cramer says wait for a day when it is not up three or four to get a better price.
Start small in KLA.
KLA is an incredibly well-run semiconductor capital equipment company needed for memory. The stock is up hugely but was down big today, so Cramer blesses starting a small position, buying 15 to 20 shares of a 100-share target, because investors are not buying it at the top.
Firefly too speculative to buy.
Space and defense continues to attract interest, but Cramer now wants companies that have some degree of earnings. He considers Firefly Aerospace too speculative.
Shell is only an okay oil.
Shell is just an okay oil company and nothing more. Cramer says he does not really care for the oils, though at least they are not speculative.
Buy Allegion into weakness.
Allegion is a good electronic security company, is not expensive, and is the kind of company investors can buy into weakness without feeling like their head will get blown off, unlike many frothy stocks.
AI competition pressures Procore.
Procore is an enterprise software company facing pressure because investors think Claude, owned by Anthropic, can create the same software product much more cheaply. Cramer does not know if Procore can be easily copied, but says that is the problem and investors must be careful.
Eli Lilly favored over Novo.
A simple tax on Novo Nordisk's principal export, Ozempic, would favor American rival Eli Lilly. Cramer says he is raising numbers on Lilly no matter what and had earlier called Lilly his favorite.
This CNBC video, published January 21, 2026,
features Jim Cramer
discussing SNDK, WDC, MU, 285A.T, GLD, SILVER, XLK, Non-data center tech, XLP, XRT, ITA, BANK, XLV, NVO, SPOT, IWM, BE, EOSE, OKLO, SMR, NNE, UEC, IMSR, ASTS, RDW, RKLB, KTOS, AVAV, RCAT, CRWV, NBIS, IREN, APLD, RIOT, GLXY, FIGR, AGQ, UAMY, CRML, XBI, RZLV, LDI, DELL, VRT, EMR, ETN, IBRX, PAAS, KLAC, Firefly Aerospace, SHEL, ALLE, PCOR, LLY.
27 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Jim Cramer
· Tickers:
SNDK,
WDC,
MU,
285A.T,
GLD,
SILVER,
XLK,
Non-data center tech,
XLP,
XRT,
ITA,
BANK,
XLV,
NVO,
SPOT,
IWM,
BE,
EOSE,
OKLO,
SMR,
NNE,
UEC,
IMSR,
ASTS,
RDW,
RKLB,
KTOS,
AVAV,
RCAT,
CRWV,
NBIS,
IREN,
APLD,
RIOT,
GLXY,
FIGR,
AGQ,
UAMY,
CRML,
XBI,
RZLV,
LDI,
DELL,
VRT,
EMR,
ETN,
IBRX,
PAAS,
KLAC,
Firefly Aerospace,
SHEL,
ALLE,
PCOR,
LLY
